Batch rollups · page 9
One row per physical lot. A lot is the unit the index cares about most, because it is the unit that repeats: two reports on one lot are two observations of one material, and everything the index says about reproducibility, inter-lab agreement and certificate accuracy is computed from that fact.
| Lot | Supplier | Compound | Manufactured | Tests | Median % | Spread pp | COA % | Divergence pp | |
|---|---|---|---|---|---|---|---|---|---|
| HJ-2511-D4010 | HJ | Ipamorelin | 19 Nov 2025 | 3 | 99.01 | 0.44 | 99.81 | +0.80 | 3+ |
| WWB-2511-L4181 | WWB | Pramlintide | 18 Nov 2025 | 1 | 99.93 | n<2 | 99.90 | -0.03 | |
| GGPE-2511-X1688 | GGPeps | Retatrutide | 18 Nov 2025 | 4 | 98.42 | 2.17 | 98.83 | +0.41 | 3+ |
| WXT-2511-P4848 | WXT | MOTS-c | 17 Nov 2025 | 1 | 98.23 | n<2 | 98.89 | +0.66 | |
| WWB-2511-S3009 | WWB | ARA-290 | 16 Nov 2025 | 10 | 99.93 | 0.51 | 99.90 | -0.03 | 3+ |
| HJ-2511-V2401 | HJ | TB-500 | 16 Nov 2025 | 1 | 99.56 | n<2 | 99.90 | +0.34 | |
| CPC-2511-F1491 | CPC | Hexarelin | 16 Nov 2025 | 13 | 98.58 | 0.89 | 98.97 | +0.39 | 3+ |
| MKM-2511-F2902 | MKM | L-Glutathione (reduced) | 15 Nov 2025 | 3 | 98.57 | 0.87 | 99.50 | +0.93 | 3+ |
| KP-2511-W5336 | KP | Exenatide | 15 Nov 2025 | 2 | 98.01 | 0.33 | 98.38 | +0.37 | |
| KP-2511-M5346 | KP | BPC-157 | 15 Nov 2025 | 17 | 98.33 | 1.25 | 98.48 | +0.15 | 3+ |
| QSC-2511-R6913 | QSC | TB-500 | 14 Nov 2025 | 2 | 99.82 | 0.23 | 99.70 | -0.12 | |
| HJ-2511-U3414 | HJ | BPC-157 | 14 Nov 2025 | 4 | 98.76 | 0.81 | 99.54 | +0.78 | 3+ |
| HJ-2511-L4170 | HJ | TB-500 | 14 Nov 2025 | 3 | 99.81 | 0.22 | 99.90 | +0.09 | 3+ |
| HOMO-2511-M1199 | Homopeptide | Melanotan II | 14 Nov 2025 | 12 | 99.06 | 1.50 | 99.90 | +0.84 | 3+ |
| WXT-2511-P5160 | WXT | Melanotan II | 13 Nov 2025 | 6 | 99.09 | 1.02 | 100.00 | +0.91 | 3+ |
| TFC-2511-E6528 | TFC | Liraglutide | 13 Nov 2025 | 5 | 98.68 | 1.57 | 99.24 | +0.56 | 3+ |
| BCH-2511-G7276 | BCH | MK-677 (Ibutamoren mesylate) | 13 Nov 2025 | 13 | 98.35 | 0.99 | 98.61 | +0.26 | 3+ |
| WXT-2511-S5991 | WXT | Leuprolide | 12 Nov 2025 | 8 | 98.32 | 0.97 | 98.21 | -0.11 | 3+ |
| TFC-2511-C8532 | TFC | BPC-157 | 11 Nov 2025 | 3 | 98.60 | 0.22 | 99.00 | +0.40 | LINKED |
| KP-2511-K4263 | KP | Retatrutide | 11 Nov 2025 | 9 | 97.12 | 1.02 | 97.46 | +0.34 | 3+ |
| HOMO-2511-G9197 | Homopeptide | Semaglutide | 11 Nov 2025 | 3 | 99.77 | 0.38 | 99.90 | +0.13 | 3+ |
| SSA-2511-W7415 | SSA | MOTS-c | 10 Nov 2025 | 6 | 98.17 | 1.20 | 98.41 | +0.24 | 3+ |
| FGP-2511-H2692 | FGP | Thymosin α1 | 10 Nov 2025 | 3 | 98.89 | 1.14 | 99.72 | +0.83 | 3+ |
| ERP-2511-L7123 | ERP | TB-500 | 10 Nov 2025 | 8 | 98.88 | 1.08 | 99.35 | +0.47 | 3+ |
| QYB-2511-Y5015 | QYB | ARA-290 | 09 Nov 2025 | 5 | 99.83 | 1.47 | 99.90 | +0.07 | 3+ |
| QSC-2511-N8732 | QSC | BPC-157 | 09 Nov 2025 | 15 | 99.93 | 0.24 | 99.90 | -0.03 | 3+ |
| QSC-2511-N7625 | QSC | Tirzepatide | 09 Nov 2025 | 2 | 99.10 | 0.96 | 99.86 | +0.76 | |
| GLBI-2511-M8631 | GL Biochem | Exenatide | 08 Nov 2025 | 1 | 98.21 | n<2 | 98.71 | +0.50 | |
| WWB-2511-M1961 | WWB | Ipamorelin | 07 Nov 2025 | 3 | 99.93 | 0.26 | 99.90 | -0.03 | 3+ |
| SWB-2511-Y5187 | SWB | CJC-1295 with DAC | 07 Nov 2025 | 1 | 98.72 | n<2 | 99.04 | +0.32 | |
| SGN-2511-G1523 | SGN | Epitalon | 07 Nov 2025 | 1 | 99.56 | n<2 | 99.77 | +0.21 | |
| QYB-2511-H6699 | QYB | TB-500 | 07 Nov 2025 | 14 | 99.39 | 0.78 | 99.52 | +0.13 | 3+ |
| WWB-2511-C2485 | WWB | GHRP-6 | 06 Nov 2025 | 1 | 99.93 | n<2 | 99.90 | -0.03 | |
| TFC-2511-S4569 | TFC | BPC-157 | 06 Nov 2025 | 1 | 99.92 | n<2 | 99.90 | -0.02 | |
| TFC-2511-L5476 | TFC | AOD-9604 | 06 Nov 2025 | 14 | 99.69 | 0.75 | 99.90 | +0.21 | 3+ |
| TFC-2511-C6410 | TFC | Selank | 06 Nov 2025 | 6 | 99.92 | 0.57 | 99.90 | -0.02 | 3+ |
| HJ-2511-L3998 | HJ | L-Glutathione (reduced) | 06 Nov 2025 | 1 | 99.02 | n<2 | 99.76 | +0.74 | |
| QYB-2511-V5143 | QYB | Liraglutide | 05 Nov 2025 | 8 | 99.17 | 1.22 | 99.71 | +0.54 | 3+ |
| SSA-2511-N7115 | SSA | Tirzepatide | 04 Nov 2025 | 2 | 98.04 | 0.85 | 97.99 | -0.05 | |
| QYB-2511-V6148 | QYB | Thymosin α1 | 04 Nov 2025 | 1 | 99.44 | n<2 | 100.50 | +1.06 |